Story perspectives

Trump Administration Signs Secret Drug Pricing Deals, Limits Savings

By Drooid · Sep 21, 2026, 6:00 AM UTC · How we work

Summary

Story summary

The U.S. President Donald Trump administration signed secret drug-pricing agreements that give Big Pharma undisclosed benefits.
Public Citizen’s FOIA records reveal the agreements let drugmakers raise overseas prices while limiting U.S. savings.
A Novo Nordisk carve-out could cut potential Medicaid savings by $1.7 billion.
Sen. Elizabeth Warren condemned the administration for not publishing the deals despite HHS Secretary Robert F. Kennedy Jr.’s pledge.

1 of 1

Story summary

The U.S. President Donald Trump administration signed secret drug-pricing agreements that give Big Pharma undisclosed benefits.
Public Citizen’s FOIA records reveal the agreements let drugmakers raise overseas prices while limiting U.S. savings.
A Novo Nordisk carve-out could cut potential Medicaid savings by $1.7 billion.
Sen. Elizabeth Warren condemned the administration for not publishing the deals despite HHS Secretary Robert F. Kennedy Jr.’s pledge.